By 2040, worldwide cases of glaucoma are expected to increase 74%, but the potential for artificial intelligence technology to diagnose and manage the disease is vast.
AI has become the state-of-the-art method used for vision tasks such as image classification, and deep learning algorithms have been used successfully in ophthalmology to detect symptoms of diabetic retinopathy, age-related macular degeneration and glaucomatous disease on photographs.
“At present, AI is not being used clinically for glaucoma as the clinical use of AI in ophthalmology is limited to diabetic retinopathy